Wave Life Sciences Statistics
NASDAQ: WVEHealth CareBiotechnology: Pharmaceutical PreparationsUSD
3.47-0.075 (-2.12%)
Market open · Delayed 15 min · as of Oct 8, 2:17 PM ET
Wave Life Sciences by the numbers
Wave Life Sciences has a market capitalization of $682.8 million based on 197.05M shares outstanding. With trailing EPS of $-1.08, Wave Life Sciences is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 28.2% below its 50-day average and 59.2% below its 200-day average.
Average daily trading volume is 3.10M shares, or about $10.7 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
WVE valuation vs. peer median
| Metric | WVE | Peer median | Difference |
|---|---|---|---|
| Market cap | $682.77M | $714.35M | -4% |
| Avg. volume | 3.10M | 675.93K | +359% |
Peer median across 8 companies: OLMA, AVTX, PHAR, COLL, NVCT, DSGN, VSTM, GYRE.
Valuation
- Market cap
- $682.77M
- EPS (TTM)
- $-1.08
- Shares outstanding
- 197.05M
Price and trading
- Previous close
- 3.54
- Open
- 3.48
- Day range
- 3.37 – 3.51
- 52-week range
- 3.37 – 21.73
- 52-week change
- -50.76%
- Beta
- —
- Volume
- 1.62M
- Average volume
- 3.10M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Jul 30, 2026
Additional statistics
- Market Cap
- 682.77M
- Forward Pe
- -2.99
- Eps
- -1.08
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 21.73
- Week52 Low
- 3.37
- Avg Volume
- 3.10M
- Shares Outstanding
- 197.05M
- Ma50
- 4.83
- Ma200
- 8.50
- Earnings Date
- Jul 30, 2026
- Pct From52w High
- -84.05%
- Pct From52w Low
- 2.97%